Clinical Trials in San Francisco

Showing 4281-4300 of 12,991 trials

Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy

NCT02099864

This phase II trial studies genetic and molecular mechanisms in assessing response in patients with prostate cancer receiving enzalutamide therapy. Androgens can cause the growth of prostate cancer cells. Antihormone therapy, such as enzalutamide, may lessen the amount of androgens made by the body. Studying samples of tissue and blood in the laboratory from patients with prostate cancer may help doctors better understand castration-resistant prostate cancer. It may also help doctors make improvements in prostate cancer treatment.

Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Soft Tissues+4 more

OHSU Knight Cancer Institute36 participantsStarted Feb 2014

San Francisco, California, United States • Portland, Oregon, United States

COMPLETEDPhase 3< 1 mile

A Safety and Efficacy Study in Patients With Gastric Cancer

NCT00400179

This is an open-label, international, two-arm, parallel, randomized, Phase 3 study evaluating the efficacy and safety of S-1/cisplatin versus 5-FU/cisplatin in patients with advanced gastric cancer previously untreated with chemotherapy for advanced disease. Patients will be randomly assigned (1:1) to S-1/cisplatin (experimental arm) or 5-FU/cisplatin (control arm). Patients will be stratified by number of metastatic sites (one vs. more than one), locally advanced or metastatic disease, prior adjuvant therapy (yes or no), measurable or non-measurable disease, and center.

Gastric Cancer

Taiho Oncology, Inc.1,053 participantsStarted May 2005

Huntsville, Alabama, United States • Burbank, California, United States • Gilroy, California, United States +30 more locations

Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy

A Safety and Efficacy Study in Patients With Gastric Cancer

Find Trials by Condition in San Francisco

Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

2021 PMT iAge® Intervention Trial by Edifice Health

The Galleri® Community Research Program

S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)

Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis

Umbilical Cord Milking in Non-Vigorous Infants

A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers

PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)

Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)

A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1

Clinical Trial Comparing C-Brace to Knee Ankle Foot Orthosis (KAFO)/Stance Control Orthosis (SCO)

Health Outcomes of Parents With Cystic Fibrosis

Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities

Pilot Trial of the RUBI Program for Autistic Adults